ABM RESPIRATORY CARE PRESENTS IN-VITRO EVIDENCE OF BIWAZE COUGH – QNT Press Release


White Paper – Evaluation and Comparison of Cough Efficiency

SINGAPORE and EAGAN, Minn., May 20, 2022 /PRNewswire/ — ABM Respiratory Care, a medical technology company focused on developing and globally commercializing novel integrated airway clearance and ventilation solutions, has published a white paper that evaluates and compares the performance of two assisted cough therapy devices. The white paper was written by Respiratory Therapists from Seattle Children’s Hospital and includes a series of bench studies. The BiWaze Cough System was compared to the CoughAssist T70 by evaluating effects of delivered therapy on flow, pressure, and cough efficiency within a mechanical lung model.

Top take aways from the white paper include:

  • BiWaze Cough was shown to generate physiologic airflow and pressure patterns with mechanically assisted cough maneuvers that closely mimic natural voluntary cough patterns observed in humans.
  • The BiWaze Cough showed higher cough efficiency based on clinical values ​​associated with enhanced secretion removal from the…

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center